|Bid||21.480 x 2900|
|Ask||21.490 x 1000|
|Day's Range||21.264 - 21.670|
|52 Week Range||10.850 - 33.820|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
You might not be aware of it, but big pharma stocks have gone through a difficult period for many years. A lot of the big drugs at the big pharma stocks went off patent, and the revenue for some of the big pharma stocks has fallen off as a result. Some of the big pharma stocks were able to replace that revenue and some weren’t.
On CNBC's "Mad Money Lightning Round" , Jim Cramer advised his viewer to hold his long position in Sirius XM Holdings Inc (NASDAQ: SIRI ). He has been recommending the stock since $4 and he is ...
Jim Cramer flies through his take on callers' favorite stocks, including a meal-kit play that's finding its footing.
Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay. Teva and Eli Lilly are in a race to put a second migraine drug on the market, after rival Amgen won FDA approval last week for Aimovig to prevent migraine headaches in adults. Lilly has said it expects an FDA decision on its galcanezumab drug by the third quarter.
Israeli drugmaker Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as early as mid-September, after an initial delay. Teva had hoped to receive approval for the drug, ...
While Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA) faded from last Wednesday highs, shares ultimately climbed about 3% that day. No, it wasn’t earnings or a new drug that gave TEVA stock a bump. Instead, it was Warren Buffett.
Roche’s (RHHBY) MabThera/Rituxan reported revenues of 1.7 billion Swiss francs in the first quarter compared to 1.9 billion Swiss francs in the first quarter of 2017, which reflected a decline of ~8% YoY (year-over-year) on constant exchange rate basis.
The biotech analysts at Cantor Fitzgerald have a packed calendar: here are some of the dates they’re tracking and why they’re important. Mallinckrodt PLC (NYSE: MNK ) is expected to release Phase 4 interim ...
Novartis' (NVS) CGRP antibody, Aimovig gains FDA approval for prevention of migraine. Zoetis (ZTS) and Lilly (LLY) announce deals to buy smaller companies.
America's favorite investor doubled down on a bet that this trainwreck isn't as bad as it looks. Should you follow?
Warren Buffett, the billionaire investor and famed Oracle of Omaha, saw the stock portfolio of his Berkshire Hathaway decline by about $2 billion in Q1, according to recent filings with the SEC. The top five positions in Buffett's portfolio represent a whopping two thirds of the entire 13F investment package for the company. As of the end of March, AAPL was the largest portfolio stake for Berkshire Hathaway, accounting for more than 21% of the company's investments, according to its 13F filing.
Teva Pharmaceutical (TEVA) provided an increased guidance for this fiscal year during its first-quarter earnings release on May 3. The company has made an upward revision to its guidance for this fiscal year. Teva reported better-than-expected results in the fiscal first quarter.
Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A ) (NYSE: BRK-B ) filed its 13F for the first quarter on Tuesday, revealing what changes it made to its portfolio during the period. The company’s equity ...
((Corrects ninth paragraph in May 15 article because of data error, and to show that Berkshire Hathaway is Apple's third-largest shareholder, trailing Vanguard Group and BlackRock, not its second-large) ...
Teva Pharmaceutical (TEVA) has been working towards paying down the high level of debt on its balance sheet. Teva obtained the debt in 2016 to fund the acquisition of Allergan’s (AGN) generic business. At the end of fiscal 2017, Teva had a net debt of $31.5 billion on its balance sheet.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock has been decimated over the years. This morning the stock is rallying on the news that the famed investor Warren Buffett doubled his stake in Teva stock. Wall Street loves to chase Buffett’s investments.
Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest ...
On May 14, Teva (TEVA) stock increased ~5.5% on the news of the expected delay in the FDA approval for rival Perrigo’s (PRGO) generic version of Teva’s asthma inhaler ProAir. On May 14, Teva stock closed at a trading price of $20.38 per share.
Analysts expect AstraZeneca (AZN) to report EPS (earnings per share) of $0.60 on revenue of $5.3 billion in the first quarter, a 2.3% fall compared to its revenue of $5.4 billion during the first quarter of 2017. AstraZeneca’s stock price has risen nearly 7.1% over the last 12 months and ~4.9% year-to-date.
Eli Lilly's (LLY) galcanezumab meets the primary endpoint in a late-stage study evaluating it for the prevention of episodic cluster headache.
The Dow Jones industrials lagged Wednesday's early action as the market defended narrow gains. Teva, Macy's, Boot Barn and China's Tencent set up early leads.